The key to successful eradication of H. pylori, using lansoprazole or rabeprazole based triple therapy, is clarithromycin resistance, not CYP2C19 polymorphism

Miki, Ikuya; Aoyama, Nobuo; Sakai, Toshiyuki; Shirasaka, Daisuke; Ebara, Shigeyuki; Wambura, Casmir; Watanabe, Yoshihori; Kachi, Masaaki; Tamura, Takao; Miyamoto, Masaki; Kasuga, Masato

期刊名称Gastroenterology
作者Miki, Ikuya; Aoyama, Nobuo; Sakai, Toshiyuki; Shirasaka, Daisuke; Ebara, Shigeyuki; Wambura, Casmir; Watanabe, Yoshihori; Kachi, Masaaki; Tamura, Takao; Miyamoto, Masaki; Kasuga, Masato
卷第120卷
期第5期
印刷ISSN0016-5085
文件大小175.57KB
发表时间2001-04
DOI10.1016/S0016-5085(08)82921-6

发现好书期刊，享受阅读乐趣

The key to successful eradication of H. pylori, using lansoprazole or rabeprazole based triple therapy, is clarithromycin resistance, not CYP2C19 polymorphism